FDMT ▼ -1.2% - 4D Molecular Therapeutics, Inc. $FDMT - 4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME 28-SEP-2026 08:01 AM ET